Trial Profile
PHASE I/II STUDY OF TEMOZOLOMIDE COMBINED WITH ORAL ETOPOSIDE IN CHILDREN AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SUPRATENTORIAL PNET/MEDULLOBLASTOMA COHORT A , AND MALIGNANT GLIAL TUMOUR COHORT B.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Etoposide (Primary) ; Temozolomide (Primary)
- Indications Brain cancer; Glioma; Medulloblastoma; Primitive neuroectodermal tumours
- Focus Adverse reactions
- 03 Jun 2011 New trial record